All News

The updated 2018 immunization schedules for children and teens has been released by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP).

Thirty-five percent of drug approvals in 2017 were personalized drugs.

With more biosimilars poised to enter the market, stakeholders seek to ensure safety and efficacy.

The RAISE Family Caregivers Act aids individuals taking care of loved ones with chronic diseases.

Cutaneous T-cell lymphoma treatment may increase the risk of death among certain patients.

Apomorphine sublingual film may treat motor fluctuations in patients with Parkinson’s disease.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Ion channel inhibitors show promise reducing the high cost of conventional hepatitis C virus antiviral therapies.

Tiotropiumis is an inhaled anticholinergic bronchodilator approved by the FDA for long-term use in patients with asthma and COPD.

Hearing loss can result from numerous therapeutic drugs and industrial chemicals.

Using the alphabet to cover everything from our job duties to our character traits.

Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending.

The American College of Rheumatology said a recent Medicare rule may affect prescription drug access.

EB-101 is the only gene therapy that has received this designation for Epidermolysis Bullosa.

The National Institutes of Health will fund research on somatic cell genome editing to provide safe and effective treatments in the future.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Identifying and overcoming resistance to the use of generic HIV medications is becoming increasingly important to lower drug costs.

Ferumoxytol (Feraheme) treats adult patients with iron deficiency anemia who have an intolerance or unsatisfactory response to oral iron.

The combination of nivolumab (Opdivo) and ipilimumab (Yervoy) improved progression-free survival (PFS) compared with chemotherapy in treatment-naïve patients with high tumor mutation burden (TMB) non–small cell lung cancer (NSCLC).

Our minds and beliefs can be used to augment therapy in effective and optimal treatment strategies.

Although it is unclear what constitutes “unusual or disproportionate,” such phrases are particularly disturbing when we realize that the regulation of medical practice is a traditional state function, not a federal one.

Pharmacists, especially those in a retail setting, are feeling the pressure.

Meal planning shouldn't be another task to check off your to do list! Here are some easy, fun ways to make meal prep enjoyable and healthy!

Top articles of the week from The American Journal of Pharmacy Benefits.

The FDA updated the labeling for rilipivirine (Edurant) for the treatment of HIV-positive pregnant patients who were on stable treatment prior to conception and who are virologically suppressed.

In 2017, the match rate for pharmacy residencies was just 69%, so the pressure is on for interviewees.

The US Food and Drug Administration has approved Allergan's supplemental New Drug Application to expand the approved use of their cephalosporin / beta-lactamase inhibitor combo antibiotic, AVYCAZ (ceftazidime and avibactam), to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the following susceptible Gram-negative microorganisms: Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Serratia marcescens, Proteus mirabilis, Pseudomonas aeruginosa, and Haemophilus influenzae in patients 18 years of age or older.

Natural Cycles is a EU-cleared application to help women avoid pregnancy, but recently there have been some concerns about how well it works.